Mirili, C. Et Al. 2019. Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results. Medical Science and Discovery , vol.6, no.12 , 327-332.

Mirili, C., Kahraman, Ç., Yılmaz, A., Bilici, M., Tekin, S. B., Tatar, A., ... Yakar, Ö.(2019). Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results. Medical Science and Discovery , vol.6, no.12, 327-332.

Mirili, Cem Et Al. "Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results," Medical Science and Discovery , vol.6, no.12, 327-332, 2019

Mirili, Cem Et Al. "Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results." Medical Science and Discovery , vol.6, no.12, pp.327-332, 2019

Mirili, C. Et Al. (2019) . "Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results." Medical Science and Discovery , vol.6, no.12, pp.327-332.

@article{article, author={Cem Mirili Et Al. }, title={Clinical results and importance of next-generation sequencing (NGS) in detecting targeted mutations in the treatment of metastatic Lung Cancer: Single center initial results}, journal={Medical Science and Discovery}, year=2019, pages={327-332} }